Sodium Phenylbutyrate
(soe' dee um fen'' il bue' ti rate).
Click to View Image

C10H11NaO2
186.18
Benzenebutanoic acid, sodium salt;    

Sodium 4-phenylbutyrate;    

Sodium 4-phenylbutanoate.    
[1716-12-7].
DEFINITION
Sodium Phenylbutyrate contains NLT 99.0% and NMT 101.0% of sodium phenylbutyrate (C10H11NaO2), calculated on the anhydrous basis.
IDENTIFICATION
•  B. Identification Tests—General, Sodium 191
Sample solution:  Dissolve 150 mg in 2 mL of water.
Acceptance criteria:  Meets the requirements of the pyroantimonate precipitation test
ASSAY
•  Procedure
Sample:  150 mg
Analysis:  Disperse the Sample in 50 mL of anhydrous acetic acid. [Note—The opalescence of the solution disappears during the titration. ] Titrate with 0.1 N perchloric acid VS, determining the endpoint potentiometrically. Each mL of 0.1 N perchloric acid is equivalent to 18.62 mg of sodium phenylbutyrate (C10H11NaO2).
Acceptance criteria:  99.0%–101.0% on the anhydrous basis
IMPURITIES
Delete the following:
•  Heavy Metals, Method I 231
Test preparation:  Dissolve 2.0 g in a 20-mL mixture of dehydrated alcohol and water (75:25).
Standard lead solution:  Prepare as directed in the chapter, except use a mixture of dehydrated alcohol and water (75:25) instead of water.
Acceptance criteria:  NMT 10 ppm(Official 1-Dec-2015)
•  Limit of Phenylbutyrate Related Compound C
Silylation solution:  To 2 mL of bis(trimethylsilyl)trifluoroacetamide add 0.04 mL of chlorotrimethylsilane, and mix.
Sample solution:  Dissolve 50.0 mg of Sodium Phenylbutyrate in 3 mL of water, and add 0.5 mL of hydrochloric acid. Extract with 2 quantities, each of 5 mL, of methylene chloride. Evaporate the combined methylene chloride extracts to dryness in a vial with a screw cap, and add 0.5 mL of the Silylation solution. Seal the vial, and heat at 70 ± 5 for 20 min.
Standard stock solution:  0.5 mg/mL of USP Phenylbutyrate Related Compound C RS in methylene chloride
Diluted standard stock solution:  0.05 mg/mL of USP Phenylbutyrate Related Compound C RS in methylene chloride from Standard stock solution
Standard solution:  Place an amount of the Diluted standard stock solution, equivalent to 0.05 mg, in a vial with a screw cap, evaporate to dryness, and add 0.5 mL of the Silylation solution. Seal the vial, and heat at 70 ± 5 for 20 min.
System suitability solution:  Prepare a solution containing 0.4 mg/mL of USP Sodium Phenylbutyrate RS in water. To 3 mL of this solution add 0.1 mL of hydrochloric acid. Extract with 2 quantities, each of 5 mL, of methylene chloride. Combine the methylene chloride extracts in a vial with a screw cap, and add 2 mL of Standard stock solution. Evaporate to dryness, and add 0.5 mL of the Silylation solution. Seal the vial, and heat at 70 ± 5 for 20 min.
Chromatographic system 
Mode:  GC
Detector:  Flame ionization
Column:  25-m × 0.25-mm fused silica capillary; coated with a 1.0-µm film of phase G27
Temperatures 
Injector:  270
Detector:  270
Column:  See Table 1.
Table 1
Initial
Temperature
()
Temperature
Ramp
(/min)
Final
Temperature
()
Hold Time
at Final
Temperature
(min)
50 0 50 5
50 10 270 5
Carrier gas:  Helium
Flow rate:  0.9 mL/min
Injection volume:  1 µL
Split ratio:  1:100
System suitability 
Sample:  System suitability solution
[Note—The relative retention times for phenylbutyrate related compound C and phenylbutyrate are about 0.98 and 1.0, respectively. ]
Suitability requirements 
Resolution:  NLT 3.0 between the phenylbutyrate related compound C and phenylbutyrate peaks
Analysis 
Samples:  Standard solution and Sample solution
Calculate the percentage of phenylbutyrate related compound C in the portion of Sodium Phenylbutyrate taken:
Result = (rU/rS) × (WS/WU) × 100

rU== peak response of phenylbutyrate related compound C from the Sample solution
rS== peak response of phenylbutyrate related compound C from the Standard solution
WS== amount of USP Phenylbutyrate Related Compound C RS taken to prepare the Standard solution (mg)
WU== amount of Sodium Phenylbutyrate taken to prepare the Sample solution (mg)
Acceptance criteria:  NMT 0.1%
•  Organic Impurities
Mobile phase:  Methanol, glacial acetic acid, and water (49:1:50)
Impurity stock solution A:  0.1 mg/mL of USP Phenylbutyrate Related Compound A RS in methanol
Impurity standard solution A:  Dilute 1.0 mL of Impurity stock solution A with water to 50.0 mL. This solution contains 2 µg/mL of USP Phenylbutyrate Related Compound A RS.
Impurity stock solution B:  0.02 mg/mL of USP Phenylbutyrate Related Compound B RS in methanol
Impurity standard solution B:  Dilute 1.0 mL of Impurity stock solution B with water to 50.0 mL. This solution contains 0.4 µg/mL of USP Phenylbutyrate Related Compound B RS.
System suitability solution:  Prepare a solution containing 20 mg/mL of USP Sodium Phenylbutyrate RS in methanol. Transfer 10 mL of this solution to a 50-mL volumetric flask, add 1.0 mL of Impurity stock solution B, and dilute with water to volume.
Sensitivity solution:  Dilute 6.0 mL of Impurity standard solution A with water to 10.0 mL. This solution contains 1.2 µg/mL of USP Phenylbutyrate Related Compound A RS.
Sample solution:  4.0 mg/mL of Sodium Phenylbutyrate, prepared as follows. Dissolve it first in methanol, using 20% of the final volume, and dilute with water to volume.
Chromatographic system 
Mode:  LC
Detector:  UV 245 nm
Column:  4.6-mm × 25-cm; 5-µm base-deactivated end-capped packing L1
Flow rate:  1.3 mL/min
Injection volume:  20 µL
System suitability 
Samples:  System suitability solution and Sensitivity solution
Suitability requirements 
Resolution:  NLT 6 between phenylbutyrate and phenylbutyrate related compound B, System suitability solution
Signal-to-noise ratio:  NLT 10, Sensitivity solution
Analysis 
Samples:  Impurity standard solution A, Impurity standard solution B, and Sample solution
Calculate the percentage of phenylbutyrate related compound A or phenylbutyrate related compound B in the portion of Sodium Phenylbutyrate taken:
Result = (rU/rS) × (CS/CU) × 100

rU== peak response of respective impurity in the Sample solution
rS== peak response of phenylbutyrate related compound A or phenylbutyrate related compound B in the respective Impurity standard solution
CS== concentration of USP Phenylbutyrate Related Compound A RS or USP Phenylbutyrate Related Compound B RS in the respective Impurity standard solution (mg/mL)
CU== concentration of Sodium Phenylbutyrate in the Sample solution (mg/mL)
Calculate the percentage of any individual unspecified impurity in the portion of Sodium Phenylbutyrate taken:
Result = (rU/rS) × (CS/CU) × 100

rU== peak response of each unspecified impurity in the Sample solution
rS== peak response of phenylbutyrate related compound A in Impurity standard solution A
CS== concentration of USP Phenylbutyrate Related Compound A RS in Impurity standard solution A (mg/mL)
CU== concentration of Sodium Phenylbutyrate in the Sample solution (mg/mL)
Acceptance criteria:  See Table 2. Disregard any peak below 0.03%.
Table 2
Name Relative
Retention
Time
Acceptance
Criteria,
NMT (%)
Phenylbutyrate related compound A 0.3 0.1
Phenylbutyrate related compound B 0.7 0.01
Sodium phenylbutyrate 1.0
Any individual unspecified Impurity 0.05
Total impurities 0.1
SPECIFIC TESTS
•  pH 791
Sample solution:  20 mg/mL in carbon dioxide-free water
Acceptance criteria:  6.5–7.5
ADDITIONAL REQUIREMENTS
•  Packaging and Storage: Preserve under argon in tight containers. Store at room temperature.
•  USP Reference Standards 11
USP Sodium Phenylbutyrate RS Click to View Structure
USP Phenylbutyrate Related Compound A RS
3-Benzoylpropionic acid;

4-Oxo-4-phenylbutanoic acid.

    C10H10O3    
    178.18
USP Phenylbutyrate Related Compound B RS
-Tetralone;

3,4-Dihydronaphthalen-1(2H)-one.

    C10H10O    
    146.19
USP Phenylbutyrate Related Compound C RS
4-Cyclohexylbutanoic acid.

    C10H18O2    
    170.25
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Elena Gonikberg, Ph.D.
Director - Chemical Medicines
(301) 816-8251
(SM32010) Monographs - Small Molecules 3
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
USP38–NF33 Page 5328
Pharmacopeial Forum: Volume No. 39(4)